We are live on ! Find out more
PR

Payden & Rygel Portfolio holdings

AUM $1.3B
1-Year Est. Return 28.32%
This Fund
S&P 500
This Quarter Est. Return
-1.03%
1 Year Est. Return
+28.32%
3 Year Est. Return
+89.13%
5 Year Est. Return
+123.15%
10 Year Est. Return
+353.66%
AUM
$1.93B
AUM Growth
-$170M
Cap. Flow
-$137M
Cap. Flow %
-7.13%
Top 10 Hldgs %
21.78%
Holding
141
New
15
Increased
29
Reduced
46
Closed
14

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$24.5M
2
MDLZ icon
Mondelez International
MDLZ
+$23M
3
TGT icon
Target
TGT
+$22.2M
4
VICI icon
VICI Properties
VICI
+$21M
5
CAT icon
Caterpillar
CAT
+$20.9M

Top Sells

Rank Stock Value
1
DOV icon
Dover
DOV
+$35.9M
2
XOM icon
ExxonMobil
XOM
+$33.6M
3
SBUX icon
Starbucks
SBUX
+$32.9M
4
QCOM icon
Qualcomm
QCOM
+$28.5M
5
VLO icon
Valero Energy
VLO
+$27.1M

Sector Composition

Rank Sector Weight
1 Financials 20.45%
2 Healthcare 17.89%
3 Technology 11.22%
4 Consumer Staples 10.63%
5 Consumer Discretionary 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CMCSA icon
1
Comcast
CMCSA
$79.1B
$49.2M 2.55%
879,465
-1,900
-0.2% -$111K
JPM icon
2
JPMorgan Chase
JPM
$939B
$47.3M 2.46%
289,056
-4,200
-1% -$658K
GS icon
3
Goldman Sachs
GS
$313B
$44M 2.29%
116,510
-18,700
-14% -$7.3M
CVS icon
4
CVS Health
CVS
$137B
$43.7M 2.27%
514,579
+235,300
+84% +$19.7M
MS icon
5
Morgan Stanley
MS
$337B
$43.3M 2.25%
445,000
-112,100
-20% -$11.1M
BMY icon
6
Bristol-Myers Squibb
BMY
$127B
$42.4M 2.2%
716,160
+371,460
+108% +$24.5M
BAC icon
7
Bank of America
BAC
$435B
$39.3M 2.04%
926,190
-154,400
-14% -$6.22M
V icon
8
Visa
V
$677B
$39.2M 2.03%
176,000
+69,600
+65% +$16.3M
MRK icon
9
Merck
MRK
$324B
$36.1M 1.87%
480,510
+58,900
+14% +$4.48M
SPY icon
10
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$35.3M 1.83%
82,308
+3,450
+4% +$1.52M
WMB icon
11
Williams Companies
WMB
$90.5B
$34.7M 1.8%
1,337,570
+6,070
+0.5% +$153K
LLY icon
12
Eli Lilly
LLY
$1.07T
$34.6M 1.8%
149,725
+32,500
+28% +$8.02M
C icon
13
Citigroup
C
$222B
$33.2M 1.72%
473,642
-177,900
-27% -$12.4M
ABT icon
14
Abbott
ABT
$180B
$33.2M 1.72%
280,630
– –
WMT icon
15
Walmart Inc
WMT
$871B
$32.8M 1.7%
705,150
-2,400
-0.3% -$116K
KO icon
16
Coca-Cola
KO
$354B
$32.5M 1.69%
619,270
-2,100
-0.3% -$117K
NEE icon
17
NextEra Energy
NEE
$187B
$32.3M 1.68%
411,200
-1,300
-0.3% -$105K
PEP icon
18
PepsiCo
PEP
$186B
$32.2M 1.67%
213,900
+47,300
+28% +$7.32M
HON icon
19
Honeywell
HON
$77.1B
$31.1M 1.61%
155,330
-4,987
-3% -$1.06M
ABBV icon
20
AbbVie
ABBV
$458B
$30.3M 1.57%
280,950
+89,150
+46% +$10.2M
EMR icon
21
Emerson Electric
EMR
$82.9B
$30.2M 1.56%
320,100
-138,900
-30% -$13.9M
TXN icon
22
Texas Instruments
TXN
$255B
$29.2M 1.52%
152,132
-400
-0.3% -$76.2K
AMGN icon
23
Amgen
AMGN
$203B
$28.9M 1.5%
135,840
+3,800
+3% +$875K
PLD icon
24
Prologis
PLD
$138B
$28.8M 1.5%
230,000
-2,600
-1% -$337K
MSFT icon
25
Microsoft
MSFT
$2.84T
$27.9M 1.45%
98,830
-1,200
-1% -$349K
1
2 3 4 5

Similar funds

GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
PWP
Private Wealth Partners Mill Valley, California $1.3B AUM 26.2% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
CCFM
Clear Creek Financial Management Silverdale, Washington $1.3B AUM 20.31% 1-Year Est. Return

Payden & Rygel's Q3 2021 Portfolio in Review

As of Q3 2021, Payden & Rygel held 141 positions worth $1.93B, down 8.1% from $2.1B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Payden & Rygel withdrew a net $137M in Q3 2021, closing 14 positions and reducing 46 holdings. Its most notable exit was Starbucks, an estimated $32.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Payden & Rygel opened a new position in Mondelez International worth $21.5M.

  • Payden & Rygel's largest Q3 2021 buy was Mondelez International: 368,970 shares worth $21.5M.
  • Payden & Rygel added most to Bristol-Myers Squibb in Q3 2021, an estimated $24.5M increase.
  • Payden & Rygel's biggest Q3 2021 reduction was Dover, cutting an estimated $35.9M.
  • Payden & Rygel fully exited Starbucks in Q3 2021, selling an estimated $32.9M.
  • Payden & Rygel's ten largest holdings make up 22% of its $1.93B portfolio in Q3 2021.
  • Payden & Rygel opened 15 new positions and closed 14 in Q3 2021.
  • Payden & Rygel's portfolio value fell 8.1% quarter-over-quarter to $1.93B.

Based on Payden & Rygel's 13F filing for Q3 2021, filed 15 Nov 2021.